Irwin Simon

Mad Money host Jim Cramer said last week during a Lightning Round segment that now is a good time to invest in Tilray. Responding to a caller who asked when was the right time to get back in cannabis stocks - now or after the midterms? Cramer replied without hesitation. "...

Canadian marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) reported Friday financial results for the first fiscal quarter ended August 31, 2022, with net revenue of $153.2 million, which compares to revenue of $168.02 million for the same period last year. “Tilray Brands’...

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY), which closed its acquisition of rival Aphria, Inc. (APHA) in 2021, could face a lawsuit brought by former Aphria shareholders. Background: In 2021, after months of negotiations, Tilray and Aphria merged creating a company with a...

Tilray Brands Inc.'s (NASDAQ: TLRY) CEO Irwin Simon said on Thursday's "Cannabis Insider" that "Europe will legalize [cannabis] before the U.S." That's something that would have already happened if the war between Russia and Ukraine hadn't broken out, he added....

Tilray Brands, Inc. (NASDAQ: TLRY), a Canada-based cannabis company, announced on Tuesday that subsidiary Tilray Medical has launched a new educational platform called WeCare-MedicalCannabis to provide education about the benefits of medical cannabis to consumers and medical practitioners,...

Tilray Brands Inc. (NASDAQ: TLRY) is joining other companies that are committing to help their employees travel to other states, following SCOTUS' decision to overturn Roe v. Wade, reported Marijuana Business Daily. The Canadian cannabis giant said that it plans to pay for...

Tilray Brands' (NASDAQ: TLRY) stock has plunged nearly 30% year-to-date. However, with the company being clearer regarding its plan to become a $4 billion revenue company by fiscal 2024, as well as explaining that the target is partially affected by the M&A opportunities and cannabis...

“Almost 4:20 on 4/20, pretty exciting,” said CNBC reporter Frank Holland as he welcomed the crowd at Benzinga’s Cannabis Capital Conference before interviewing Irwin Simon, CEO of Tilray inc. (NASDAQ: TLRY), the leading global cannabis-lifestyle and consumer...

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) reported financial results for the third fiscal quarter ended Feb. 28, 2022 with net revenue up 23% from the same quarter last year reaching $152 million. “Our third quarter results reflect progress and momentum across all of our key...

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) has announced that it will release financial results for its third-quarter fiscal 2022 ended February 28, 2022, before financial markets open on April 6, 2022. The company's executives will host a live conference call and audio webcast to...

Cannabis stocks continue to rise Friday following reports the U.S. House Rules Committee plans to meet next week to prepare a federal marijuana legalization bill for floor action. While many stand back and cast doubt on the ability of the bill to make its way through the Senate, Tilray Brands...

Tilray Brands, Inc. (Nasdaq:TLRY) (TSX:TLRY) launched Renew Moonlight, a new CBN vape pen designed for nighttime use by wellness brand, Solei. Joining Solei's portfolio of wellness products, this high-CBN vape pen with a potency of 4:1 THC and CBN is blended with citrus and herbal aromas....

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) confrimed Thursday that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offering and launched the first EU GMP medical cannabis oil products in Malta. Tilray’s EU-GMP medical cannabis products are now available in...

On Thursday, HEXO Corp. (NASDAQ: HEXO) finalized a strategic partnership with Tilray Brands, Inc. (NASDAQ: TLRY), which includes a new debt financing agreement under which the Canadian cannabis giant agreed to acquire $211 million of senior secured convertible notes that were initially issued by...

Earlier this month, Aurora Cannabis (NASDAQ: ABC) reported its second-quarter financial results, revealing a 10% decline in total net revenue, which totaled slightly over $60 million, and a $75.1 million loss. The company’s CEO Miguel Martin touted a sequential improvement of $2.5 million in...